O-017 Reduction of Macrophage Derived Growth Factors and Macrophage Activity Markers during Sorafenib Treatment of Hepatocellular Carcinoma

Authors:

M. F. Sprinzl, K. Ackermann, M. Schlitter, D. Hartmann, A. Weinmann, M. Schuchmann, M. Heikenwaelder, P. R. Galle, U. Protzer